We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Viral “Molecular Scissor” Identified as a Potential COVID-19 Drug Target

News   Oct 19, 2020 | Original story from The University of Texas Health Science Center at San Antonio

 
Viral “Molecular Scissor” Identified as a Potential COVID-19 Drug Target

The SARS-CoV-2-PLpro enzyme is visualized with an inset of viral inhibitor interaction. Blocking the enzyme's effects may prove fruitful in stopping coronavirus infections. Credit: Shaun K. Olsen, PhD, laboratory at The University of Texas Health Science Center at San Antonio (Joe R. and Teresa Lozano Long School of Medicine)

 
 
Advertisement
 

RELATED ARTICLES

None of the SARS-CoV-2 Mutations Currently Documented Appear To Increase Its Transmissibility

News

Researchers have so far identified 12,706 mutations in SARS-CoV-2. For 398 of the mutations, there is strong evidence that they have occurred repeatedly and independently.

READ MORE

Model Designed To Predict Cellular Drug Targets Against COVID-19

News

A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce.

READ MORE

CAR T-Cell Therapy Shows Promising Early Results in Children With Neuroblastoma

News

A novel CAR T-cell therapy has shown promising early results in children with neuroblastoma, a rare form of childhood cancer. Twelve children with relapsed or refractory neuroblastoma were treated as part of a Phase I clinical trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE